TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Bio Forte AS
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
14,061
|
14,113
|
14,752 |
| Financial expenses |
8
|
7
|
7 |
| Earnings before taxes |
492
|
395
|
934 |
| Total assets |
4,647
|
4,311
|
4,066 |
| Current assets |
4,314
|
3,804
|
3,826 |
| Current liabilities |
1,282
|
1,325
|
1,385 |
| Equity capital |
3,365
|
2,981
|
2,674 |
| - share capital |
200
|
200
|
200 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
72.4%
|
69.1%
|
65.8% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
3.5%
|
2.8%
|
6.3% |
| Return on assets (ROA) |
10.8%
|
9.3%
|
23.1% |
| Current ratio |
336.5%
|
287.1%
|
276.2% |
| Return on equity (ROE) |
14.6%
|
13.3%
|
34.9% |
| Change turnover |
-52
|
-639
|
-1,668 |
| Change turnover % |
0%
|
-4%
|
-10% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.